We want to make medicine accessible, available, and affordable everywhere in the EU.
Our new reform of the #EUPharmaStrategy legislation proposes a single market of medicines that will:
💶 ensure affordable access,
🪫 prevent shortages,
💡 foster industry innovation,
🦠 fight antimicrobial resistance,
💚 improve environmental sustainability.
Together, we can create an innovative, patient-focused single market that is fit for the future. → https://europa.eu/!7prhmX
@EU_Commission Much needed!
I know the struggle 3 months ago when Germany was short on Paracetamol for infants :(
@EU_Commission Let's be clear, this includes patent monopoly extension that's not necessarily good for the public.
"Foster industry innovation" = "proposes a minimum period of regulatory protection of 8 years that can be extended . . . The combination of the existing intellectual property rights and the new regulatory protection periods will also safeguard the EU's competitive edge in pharmaceutical development, one of the most protective world-wide."
@EU_Commission
DE:
Hauptsache dafür bleibt nicht der Persönlichkeits-/Datenschutz auf der Strecke!
EN:
The essential thing is that personal data protection does not fall by the wayside!
